Effect of Topical Nepafenac on Central Foveal Thickness following Panretinal Photocoagulation in Diabetic Patients

Purpose. To evaluate effectiveness of topical nepafenac in reducing macular edema following panretinal photocoagulation (PRP). Design. Prospective randomized double-blinded controlled study. Methods. Sixty eyes of 60 patients having proliferative or severe nonproliferative diabetic retinopathy had P...

Full description

Saved in:
Bibliographic Details
Published in:Journal of ophthalmology 2017-01, Vol.2017 (2017), p.1-5
Main Authors: Abdel-Kader, Ahmed A., Ghalwash, D., Mohalhal, Ahmed A., Abu Hussein, Nahla B.
Format: Article
Language:English
Subjects:
Care and treatment
Cornea
Diabetes
Diabetic retinopathy
Diabetics
Dosage and administration
Edema
Eye diseases
Health aspects
Inflammation
Lasers
Light coagulation
Morphology
Nepafenac
Nonsteroidal anti-inflammatory drugs
Standard deviation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose. To evaluate effectiveness of topical nepafenac in reducing macular edema following panretinal photocoagulation (PRP). Design. Prospective randomized double-blinded controlled study. Methods. Sixty eyes of 60 patients having proliferative or severe nonproliferative diabetic retinopathy had PRP. Patients were then divided into two groups: nepafenac group (30 eyes) receiving 1% topical nepafenac eye drops for 6 months and control group (30 eyes) receiving carboxymethylcellulose eye drops for 6 months. Best-corrected visual acuity (BCVA) and macular optical coherence tomography were followed up at 1, 2, 4, and 6 months after PRP. Results. BCVA was significantly better in nepafenac group than in control group at all follow-ups (P
ISSN:2090-004X
2090-0058
DOI:10.1155/2017/3765253